The present application relates to fluoranthenylamine compounds of a formula (I). These compounds are suitable for use in electronic devices. The present application further relates to processes for preparing the compounds mentioned, and to electronic devices comprising the compounds mentioned.

Provided are a compound of Formula 1 and an organic electric element including a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode and comprising the compound, the element showing improved luminescent efficiency, stability, and life span.

Provided are a compound of Formula 1 and an organic electric element including a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode and comprising the compound, the element showing improved luminescent efficiency, stability, and life span.

The present specification relates to a heterocyclic compound represented by Chemical Formula 1 and an organic light emitting device comprising the same.

A material for an organic electroluminescent device having high emission efficiency and long life, and an organic electroluminescent device including the same. The material for an organic electroluminescent device may be represented by Formula (1). ##STR00001##

A material for an organic electroluminescent device having high emission efficiency and long life, and an organic electroluminescent device including the same. The material for an organic electroluminescent device may be represented by Formula (1). ##STR00001##

The present invention relates to a method for preparing substituted 4-aminoindane derivatives of the general formula (I) by cyclization,

##STR00001##

in which R, n, R.sup.1, R.sup.2, R.sup.3, R.sup.4, Q.sup.1 and Q.sup.2 have the definitions specified in the description.

The present invention relates to a method for preparing substituted 4-aminoindane derivatives of the general formula (I) by cyclization,

##STR00001##

in which R, n, R.sup.1, R.sup.2, R.sup.3, R.sup.4, Q.sup.1 and Q.sup.2 have the definitions specified in the description.

Provided herein are Aminopurine compounds of Formula I:

##STR00001## or pharmaceutically acceptable salts, tautomers, isotopologues, or stereoisomers thereof, wherein R.sup.1, R.sup.2, and R.sup.3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing animal and human protozoal infections.

Provided herein are Aminopurine compounds of Formula I:

##STR00001## or pharmaceutically acceptable salts, tautomers, isotopologues, or stereoisomers thereof, wherein R.sup.1, R.sup.2, and R.sup.3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing animal and human protozoal infections.